L De Rooy1, H Hamdallah2, S C Dyall3. 1. Department of Life Sciences, University of Roehampton, Whitelands College, London, UK; Neonatal Unit, St George's University Hospital, London, UK. 2. Department of Life Sciences, University of Roehampton, Whitelands College, London, UK. 3. Department of Life Sciences, University of Roehampton, Whitelands College, London, UK; Faculty of Health and Social Sciences, Bournemouth University, Dorset, UK. Electronic address: sdyall@bournemouth.ac.uk.
Abstract
BACKGROUND & AIMS: Adequate supply of arachidonic (ARA) and docosahexaenoic (DHA) acids is essential for brain development, and extremely preterm infants may be at risk of deficiency. Current levels of ARA and DHA given to extremely preterm infants and the amounts available for accretion have not been established, although recent evidence suggests DHA intake is at a level likely to lead to severe deficits. This study quantified the omega-6 and omega-3 polyunsaturated fatty acid (PUFA) intakes from all sources in the first six weeks of life of preterm infants in standard care. In addition, the relationship between blood levels of circulating cytokines and PUFAs was explored. METHODS: Single centre longitudinal study with omega-6 and omega-3 PUFA intake data analysed from all sources for 17 infants born <28 weeks gestation. At six weeks of age the infants' whole-blood fatty acid levels were measured along with a range of cytokines and chemokines analysed by Luminex® multiplex array. RESULTS: ARA intake was significantly below international recommendations in weeks 1-5 (all p < 0.05), and DHA intake was significantly below recommendations in week 1 (p < 0.0001). The amounts of ARA and DHA available for accretion were significantly below estimated accretion rates in all weeks (all p < 0.001). Mean ARA and DHA intakes were correlated with their respective blood levels (r = 0.568, p = 0.017 and r = 0.704, p = 0.002). There were significant relationships between MIP-1β and blood DHA levels (rs = 0.559, p = 0.02) and between RANTES and omega-6:omega-3 PUFA ratio (rs = -0.498, p = 0.042). CONCLUSIONS: This study establishes that extremely preterm infants receive insufficient intakes of ARA and DHA. Moreover, blood fatty acid levels may provide a useful measure of intake, where establishing sufficient consumption could have clinical importance. There may also be important interactions between long-chain PUFA status and markers of inflammation, which requires further study.
BACKGROUND & AIMS: Adequate supply of arachidonic (ARA) and docosahexaenoic (DHA) acids is essential for brain development, and extremely preterm infants may be at risk of deficiency. Current levels of ARA and DHA given to extremely preterm infants and the amounts available for accretion have not been established, although recent evidence suggests DHA intake is at a level likely to lead to severe deficits. This study quantified the omega-6 and omega-3 polyunsaturated fatty acid (PUFA) intakes from all sources in the first six weeks of life of preterm infants in standard care. In addition, the relationship between blood levels of circulating cytokines and PUFAs was explored. METHODS: Single centre longitudinal study with omega-6 and omega-3 PUFA intake data analysed from all sources for 17 infants born <28 weeks gestation. At six weeks of age the infants' whole-blood fatty acid levels were measured along with a range of cytokines and chemokines analysed by Luminex® multiplex array. RESULTS:ARA intake was significantly below international recommendations in weeks 1-5 (all p < 0.05), and DHA intake was significantly below recommendations in week 1 (p < 0.0001). The amounts of ARA and DHA available for accretion were significantly below estimated accretion rates in all weeks (all p < 0.001). Mean ARA and DHA intakes were correlated with their respective blood levels (r = 0.568, p = 0.017 and r = 0.704, p = 0.002). There were significant relationships between MIP-1β and blood DHA levels (rs = 0.559, p = 0.02) and between RANTES and omega-6:omega-3 PUFA ratio (rs = -0.498, p = 0.042). CONCLUSIONS: This study establishes that extremely preterm infants receive insufficient intakes of ARA and DHA. Moreover, blood fatty acid levels may provide a useful measure of intake, where establishing sufficient consumption could have clinical importance. There may also be important interactions between long-chain PUFA status and markers of inflammation, which requires further study.
Authors: Chatarina A Löfqvist; Svetlana Najm; Gunnel Hellgren; Eva Engström; Karin Sävman; Anders K Nilsson; Mats X Andersson; Anna-Lena Hård; Lois E H Smith; Ann Hellström Journal: JAMA Ophthalmol Date: 2018-03-01 Impact factor: 7.389
Authors: Anders K Nilsson; Chatarina Löfqvist; Svetlana Najm; Gunnel Hellgren; Karin Sävman; Mats X Andersson; Lois E H Smith; Ann Hellström Journal: Acta Paediatr Date: 2018-03-13 Impact factor: 2.299
Authors: Ann Hellström; Aldina Pivodic; Lotta Gränse; Pia Lundgren; Ulrika Sjöbom; Anders K Nilsson; Helena Söderling; Anna-Lena Hård; Lois E H Smith; Chatarina Alice Löfqvist Journal: JAMA Netw Open Date: 2021-10-01